Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001140361-15-002672

Chief Technology Officer acquired 185,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

WACHTER ERIC PHD · Chief Technology Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-01-24 Exercise or conversion : show line 1 in the form +185,000 $1.02 $188,700 824,248 I

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-01-24 Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) −185,000 800,000 D
Loading xslF345X03/doc1.xml…